Sanofi Licenses OTC Tamiflu From Roche To Attempt First US Flu Treatment Switch

Sanofi consumer health chief Alan Main says with the US the largest OTC drug market, a successful switch for Tamiflu, marketed in the US by Roche subsidiary Genentech, would support the firm's global strategy for expanding cough and cold remedy sales.

The question mark in a number of

Sanofi looks for better results than Roche once had for making Tamiflu influenza treatment available OTC in the US as the French pharma licenses exclusive rights from its Swiss counterpart for preparing a switch application and marketing the oseltamivir product if approved.

In Sanofi's July 23 announcement, its consumer health chief, Alan Main, pointed out the US is the largest OTC drug...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Europe

More from Geography